Darryl Whitney, MD
Sports Medicine · Shelton, CTNPI 1285078139
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (45.4%), education and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Arthrex at 52.8% of the total. Reporting peaked in 2019 at $32,518 and has fallen 99.5% since, to $155 in 2025.
Across 53 payments — averaging $830.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$23K
- Smith+Nephew$18K
- Stryker$2K
- Joint Restoration Foundation, Inc.$209
- Polaris Technology Solutions LLC$130
- Johnson & Johnson$80
- plus $161 from 5 others
What the payments were for
- Grants$20,00045%
- Travel & lodging$2,7536%
- Food & beverage$1,7984%
- Education$19,45444%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 18 | $23,241 |
| Smith+Nephew | 8 | $17,922 |
| Stryker | 14 | $2,262 |
| Joint Restoration Foundation, Inc. | 1 | $209 |
| Polaris Technology Solutions LLC | 2 | $130 |
| Johnson & Johnson | 3 | $80 |
| Vericel Corporation | 3 | $57 |
| Solventum Corporation | 1 | $37 |
| Ardelyx, Inc. | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| CSL Behring | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$44,004 in reported general payments places this provider in the 80th percentile of 65 sports medicine providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 43 | $836 |
| Diclofenac Sodium | 27 | $417 |
| Methocarbamol | 47 | $414 |
| Methylprednisolone | 66 | $386 |
| Tizanidine Hcl | 42 | $248 |
| Meloxicam | 95 | $237 |
| Ibuprofen | 23 | $208 |
| Cyclobenzaprine Hcl | 35 | $189 |
| Gabapentin | 13 | $176 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $173 |
| Tramadol Hcl | 14 | $92 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Shelton
- Jeffrey KlauserShelton$21K
- Augustus MazzoccaFarmington$1M
- Michael KaplanMiddlebury$385K
- Robert ArcieroFarmington$269K
- Karen SuttonStamford$245K
- Michael KuhnMiddletown$201K
- Katherine CoynerFarmington$186K
- Joshua FrankNorwalk$78K
- Michael JoyceGlastonbury$73K
- Andrew JimenezNew Haven$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.